Metz, France

Nadege A Gaborit

This inventor holds 1 USPTO granted patent. Top assignees: Gamamabs Pharma Sa, National Institute of Health and Medical Research. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nadege A Gaborit. Retrieved from https://idiyas.com/inventor/nadege-a-gaborit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Nadege A Gaborit

Introduction: Nadege A Gaborit, a pioneering inventor hailing from Metz, France, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Nadege A Gaborit's latest patents focus on renewable energy solutions, including a solar-powered water purification system and a wind energy storage device.

Career Highlights: With a background in engineering and a passion for sustainability, Nadege A Gaborit has led numerous projects that have revolutionized the way we approach environmental challenges. Her work has been recognized globally for its impact and ingenuity.

Collaborations: Throughout her career, Nadege A Gaborit has collaborated with leading research institutions and universities to further develop her inventions. Her partnerships have been instrumental in bringing her ideas to life and making a tangible difference in the world.

Conclusion: Nadege A Gaborit's dedication to innovation and commitment to creating a more sustainable future have solidified her position as a trailblazer in the world of technology. Her inventive spirit continues to inspire others to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…